Michael Arand

9.9k citations
112 papers · 7.8k · 2 hit papers · h-index 46

Impact in

  • Biochemistry top 0.1%
    • Eicosanoids and Hypertension Pharmacology
  • Immunology top 0.5%
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • Immune Cell Function and Interaction

Papers in

    • Enzyme Catalysis and Immobilization 14
    • Glutathione Transferases and Polymorphisms 10
    • Microbial Metabolic Engineering and Bioproduction 10
    • Pharmacogenetics and Drug Metabolism 40

Michael Arand

111 papers receiving 7.7k citations

Michael Arand's Hit Papers

Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes 1998 · 594 citations
5940+9+18Years since publication100200300400500

Peers

Michael Arand
Comparison fields: 5 of 147
  • Biochemistry 1.3k
  • Immunology 3.1k
  • Pharmacology 1.0k
  • Molecular Biology 4.1k
  • Oncology 1.5k
Replace Masayoshi Imagawa with:
Masayoshi Imagawa Japan
Wayne B. Anderson United States
David J. Shapiro United States
Abraham Novogrodsky Israel
Hans R. Waterham Netherlands
Hideaki Kamata Japan
Stephen J. Ralph Australia
Kazuhiro Sogawa Japan
Mark Hannink United States
Marian Orłowski United States
Michael Arand relative to Masayoshi Imagawa Japan Masayoshi Imagawa's profile →
Citations per field
00.5×4.9×
Masayoshi Imagawa · 1×
Citations per year

Countries citing papers authored by Michael Arand

Since Specialization
Citations

This map shows the geographic impact of Michael Arand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Arand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Arand more than expected).

Fields of papers citing papers by Michael Arand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Arand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Arand. The network helps show where Michael Arand may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Arand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Arand Line = papers co-authored together Michael Arand links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes
Hit paper breakdown →
1998594
2
A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens
Hit paper breakdown →
1998593
3 2000363
4 2000337
5 1996297
6 1997256
7 1996246
8 1996218
9 1996195
10 1998191
11 2000186
12 1999182
13 2009149
14 2000148
15 2005142
16 2009131
17 1994128
18 2003121
19 2003120
20 2003114

About Michael Arand

Michael Arand is a scholar working on Molecular Biology, Pharmacology, Biochemistry, Immunology and Endocrinology, Diabetes and Metabolism, having authored 112 papers that have together received 7.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (40 papers), Eicosanoids and Hypertension Pharmacology (34 papers), Biochemical Acid Research Studies (18 papers), Immunotherapy and Immune Responses (16 papers), Enzyme Catalysis and Immobilization (14 papers), T-cell and B-cell Immunology (14 papers), Glutathione Transferases and Polymorphisms (10 papers) and Microbial Metabolic Engineering and Bioproduction (10 papers). The work is most often cited by research in Biochemistry (1.3k citations), Immunology (3.1k citations), Pharmacology (1.0k citations), Molecular Biology (4.1k citations) and Oncology (1.5k citations). Michael Arand has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Franz Oesch, Julia Karbach, Alexander Knuth, Elke Jäger, Lloyd J. Old, Elisabeth Stockert, Mark Ringhoffer, Annette Cronin, Yao‐Tseng Chen and Jan G. Hengstler. Their work appears in journals such as Archives of Toxicology, Biochemical Journal, International Journal of Cancer, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact